首页> 美国卫生研究院文献>other >Phase II Study Evaluating the Addition Of Cetuximab to the Concurrent Delivery of Weekly Carboplatin Paclitaxel and Daily Radiotherapy for Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck

【2h】

Phase II Study Evaluating the Addition Of Cetuximab to the Concurrent Delivery of Weekly Carboplatin Paclitaxel and Daily Radiotherapy for Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck

机译：II期临床研究评价添加西妥昔单抗周刊卡铂紫杉醇和放疗日报的并发交付患者头颈部的局部晚期鳞状细胞癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 other
作者
Mohan Suntharalingam; Young Kwok; Olga Goloubeva; Arti Parekh; Rodney Taylor; Jeffrey Wolf; Ann Zimrin; Scott Strome; Robert Ord; Kevin J. Cullen;
展开▼
作者单位

展开▼
年(卷),期 -1(82),5
年度 -1
页码 1845–1850
总页数 15
原文格式 PDF
正文语种
中图分类
关键词
入库时间 2022-08-21 11:26:37

相似文献

外文文献
中文文献
专利

1. 不能手术的Ⅲ期非小细胞肺癌患者每周紫杉醇和卡铂并同步放疗的诱导化疗：一个Ⅱ期研究结果 [J] . Hend Ahmed El-Hadaad, Hanan Ahmed Wahba, Eman Toson 中德临床肿瘤学杂志（英文版） . 2013,第002期
2. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck [J] . SuntharalingamM., KwokY., GoloubevaO., International Journal of Radiation Oncology, Biology, Physics . 2012,第5期

机译：II期研究评估在头颈部局部晚期鳞状细胞癌患者每周卡铂，紫杉醇和每日放疗的同时分娩中添加西妥昔单抗
3. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily Radiotherapy (RT). [J] . Suntharalingam M, Jaboin J, Taylor R, Seminars in Oncology . 2004,第6Suppla18期

机译：氨磷汀在每周局部接受卡铂，紫杉醇和每日放疗（RT）治疗的晚期局部区域头颈部鳞状细胞癌（SCCHN）患者中对粘膜保护的评估。
4. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck [J] . Tomohiro Enokida, Takenori Ogawa, Akihiro Homma, Cancer Medicine . 2020,第5期

机译：紫杉醇，卡铂和西妥昔单抗的多中心期II试验，然后进行患者的头部和颈部局部晚期鳞状细胞癌的患者的化学疗法
5. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
6. EGFRvIII Expression and Signaling in head and neck squamous cell carcinoma. [D] . Wheeler, Sarah E. 2012

机译：EGFRvIII在头颈部鳞状细胞癌中的表达和信号传导。
7. A multicenter phase II trial of paclitaxel carboplatin and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck [O] . Tomohiro Enokida, Takenori Ogawa, Akihiro Homma, 2020

机译：紫杉醇卡铂和西妥昔单抗的多中心II期试验随后进行化学放疗治疗无法切除的局部晚期头颈部鳞状细胞癌
8. Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck [O] . Mohan Suntharalingam, Young Kwok, Olga Goloubeva, 2012

机译：II期研究评估加入西妥昔单抗的加入每周卡铂，紫杉醇和每日放疗的同时递送头部和颈部局部晚期鳞状细胞癌的患者

Phase II Study Evaluating the Addition Of Cetuximab to the Concurrent Delivery of Weekly Carboplatin Paclitaxel and Daily Radiotherapy for Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck

著录项

相似文献

相关主题

期刊订阅